tirzepatide long island ny Medical Weight Loss on Island, with MarottaMD Wellness in Long Island, NY

10% Experience Dizziness According to NP2GO, approximately 10% of patients experience dizziness when taking semaglutide, and early reports also note that dizziness was reported in 5% of patients during the first month of treatment, highlighting that early monitoring and simple adjustments often prevent escalation

Additionally, combination therapies such as GLP-1/GIP dual agonists are showing promise in further enhancing glycemic control and weight reduction in diabetic patients

34 SzetoH

106 The deterioration of renal function is the main reason for accelerating the occurrence and development of adverse cardiovascular events in patients with CKD

Results: At baseline, 63.7% of our non-diabetic CAD patients had prediabetes